Login / Signup

Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy.

Fanfan DuClayton H RischeYang LiMichael P VincentRebecca A Krier-BurrisYuan QianSimseok A YukSultan AlmunifBruce S BochnerBaofu QiaoEvan Alexander Scott
Published in: Nature nanotechnology (2024)
Protein adsorption onto nanomaterials often results in denaturation and loss of bioactivity. Controlling the adsorption process to maintain the protein structure and function has potential for a range of applications. Here we report that self-assembled poly(propylene sulfone) (PPSU) nanoparticles support the controlled formation of multicomponent enzyme and antibody coatings and maintain their bioactivity. Simulations indicate that hydrophobic patches on protein surfaces induce a site-specific dipole relaxation of PPSU assemblies to non-covalently anchor the proteins without disrupting the protein hydrogen bonding or structure. As a proof of concept, a nanotherapy employing multiple mast-cell-targeted antibodies for preventing anaphylaxis is demonstrated in a humanized mouse model. PPSU nanoparticles displaying an optimized ratio of co-adsorbed anti-Siglec-6 and anti-FcεRIα antibodies effectively inhibit mast cell activation and degranulation, preventing anaphylaxis. Protein immobilization on PPSU surfaces provides a simple and rapid platform for the development of targeted protein nanomedicines.
Keyphrases
  • protein protein
  • mouse model
  • amino acid
  • cancer therapy
  • drug delivery
  • high throughput
  • small molecule
  • molecular dynamics
  • staphylococcus aureus
  • biofilm formation
  • single molecule
  • quantum dots
  • human health
  • monte carlo